Switch Language

News

Please find below the last exciting news from GSV & Life Sciences Sector.

La pénurie de généralistes en Suisse retarde la prise en charge des patients

Il faut entre quinze et trente appels pour décrocher un rendez-vous chez un médecin généraliste...

More info

November 25, 2021

Santé: premier recul depuis 10 ans des hospitalisations l’an dernier à cause du coronavirus

Avec la pandémie de coronavirus, le nombre de personnes hospitalisées était en recul l’an dernier....

More info

November 25, 2021

L’OCDE attribue une bonne note au système de santé suisse

Le système de santé suisse reste l’un des meilleurs de tous les pays de l’OCDE....

More info

November 25, 2021

«À Genève, l’âge d’or des multinationales, c’est maintenant»

La crise, quelle crise? Ivan Bascle, Senior Partner et responsable du Boston Consulting Group de...

More info

November 25, 2021

Le système de santé suisse vu par Thomas Wiesel

Caisses-maladie, lobbys pharmaceutiques, personnalités politiques: l’humoriste Thomas Wiesel n’épargne personne. MORE

More info

November 25, 2021

GBL fait offre sur le champion suisse du diagnostic Unilabs

La holding des Frère-Desmarais fait partie des candidats qui se bouscoulent au portillon pour le...

More info

November 25, 2021

Top 10 Emerging Technologies of 2021 – WEF

Think of our planet’s grand challenges: managing climate change; reducing energy use; sustaining food production;...

More info

November 25, 2021

[Espace Création ] Cybersécurité : Tous concernés

Une soixantaine de participants se sont retrouvés autour d’experts de la cybersécurité cette semaine à...

More info

November 25, 2021

In Memoriam ouvre son deuxième Opus à Campus Biotech Genève

Mardi dernier s’est ouvert, à Campus Biotech, le deuxième Opus de l’exposition In Memoriam (www.inmemoriamart.ch)....

More info

November 25, 2021

IMD, UEFA & IOC teamed up at UniverCité for an innovation Challenge

The IMD Business School partnered with the International Olympic Committee – IOC and the Union of...

More info

November 25, 2021

Philips debuts AI-equipped MRI machines plus spectral angio-CT combination scanners

More info

November 24, 2021

BD snags new senior VP of investor relations from Medtronic

More info

November 24, 2021

Elizabeth Holmes admits to OK'ing shady practices at Theranos

More info

November 24, 2021

FDA halts phase 1b Kura Oncology trial in acute myeloid leukemia following patient death

More info

November 24, 2021

Chasing Regeneron, Pfizer posts data on $250M cardiovascular bet

More info

November 24, 2021

Kymera's first-in-class protein degrader shows potential to boost cancer immunotherapy

More info

November 24, 2021

Acorda CMO hits the exit, landing Pharnext job with oversight of phase 3 neurological disorder trial

More info

November 24, 2021

Rafael resets after phase 3 flop, parting ways with 5 execs and reinstating telecom tycoon as CEO

More info

November 23, 2021

Cardiologs scores pediatric heart AI diagnostic clearance from FDA ahead of Philips buyout

More info

November 23, 2021

Vaccibody, now Nykode, celebrates new name with a Regeneron deal worth $900M-plus

More info

November 23, 2021

Regulatory interaction pinpointed that could pave new pathway for treating inflammatory diseases

More info

November 23, 2021

Merck buzzes Dragonfly for 2nd immunotherapy candidate in $700M pact month after Bristol Myers' 6th opt-in

More info

November 23, 2021

Medtronic's surgery robot rollout hits supply chain speed bumps

More info

November 23, 2021

AstraZeneca, after years of delays and spiraling costs, opens Cambridge R&D site. Will the bet pay off?

More info

November 23, 2021

Reify Health taps into renewed drive to improve clinical trial diversity, releasing new tool to give drug sponsors more insight

More info

November 23, 2021

Sanifit, having put Spain's biotech scene on the map, lands $231M Vifor buyout ahead of phase 3 data

More info

November 22, 2021

Twist nabs antibody discovery biotech Abveris for $190M a week after spinning out COVID unit

More info

November 22, 2021

Xencor finally finds buyer for onetime lead drug, offloading autoimmune asset to Tesaro co-founder in backloaded deal

More info

November 22, 2021

Neurocrine pens $2.6B biobucks pact with Sosei Heptares for next-gen neuro targets

More info

November 22, 2021

BD upsizes San Diego presence with new 220K-square-foot biosciences R&D facility

More info

November 22, 2021

Roche, Genentech tap Flywheel to spin up AI-based drug discovery research

More info

November 22, 2021

GlaxoSmithKline takes aim at NASH, penning a $1B pact with RNAi biotech Arrowhead

More info

November 22, 2021

Pear's digital therapeutic for alcohol use disorder bears fruit with FDA breakthrough tag

More info

November 22, 2021

UK launches review of racial, gender biases in medical devices, sparked by disproportionate COVID deaths

More info

November 22, 2021

FDA unlocks faster clearances for future hepatitis C diagnostics

More info

November 22, 2021